Vertex Pharmaceuticals Inc (VRTX)
396.68
-4.08
(-1.02%)
USD |
NASDAQ |
Apr 25, 10:06
Vertex Pharmaceuticals Total Assets (Quarterly): 22.73B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.73B |
| September 30, 2023 | 21.73B |
| June 30, 2023 | 20.35B |
| March 31, 2023 | 18.97B |
| December 31, 2022 | 18.15B |
| September 30, 2022 | 16.71B |
| June 30, 2022 | 15.58B |
| March 31, 2022 | 14.26B |
| December 31, 2021 | 13.43B |
| September 30, 2021 | 12.62B |
| June 30, 2021 | 12.22B |
| March 31, 2021 | 12.12B |
| December 31, 2020 | 11.75B |
| September 30, 2020 | 11.30B |
| June 30, 2020 | 10.22B |
| March 31, 2020 | 8.893B |
| December 31, 2019 | 8.318B |
| September 30, 2019 | 7.515B |
| June 30, 2019 | 7.033B |
| March 31, 2019 | 6.543B |
| December 31, 2018 | 6.246B |
| September 30, 2018 | 4.621B |
| June 30, 2018 | 4.335B |
| March 31, 2018 | 3.953B |
| December 31, 2017 | 3.546B |
| Date | Value |
|---|---|
| September 30, 2017 | 3.198B |
| June 30, 2017 | 3.286B |
| March 31, 2017 | 2.947B |
| December 31, 2016 | 2.897B |
| September 30, 2016 | 2.610B |
| June 30, 2016 | 2.549B |
| March 31, 2016 | 2.488B |
| December 31, 2015 | 2.499B |
| September 30, 2015 | 2.434B |
| June 30, 2015 | 2.374B |
| March 31, 2015 | 2.166B |
| December 31, 2014 | 2.335B |
| September 30, 2014 | 2.406B |
| June 30, 2014 | 2.118B |
| March 31, 2014 | 2.197B |
| December 31, 2013 | 2.319B |
| September 30, 2013 | 2.583B |
| June 30, 2013 | 2.584B |
| March 31, 2013 | 2.392B |
| December 31, 2012 | 2.759B |
| September 30, 2012 | 2.719B |
| June 30, 2012 | 2.605B |
| March 31, 2012 | 2.346B |
| December 31, 2011 | 2.204B |
| September 30, 2011 | 2.092B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.033B
Minimum
Jun 2019
22.73B
Maximum
Dec 2023
13.89B
Average
12.62B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 97.15B |
| Eli Lilly and Co | 64.01B |
| Regeneron Pharmaceuticals Inc | 33.08B |
| Alpine Immune Sciences Inc | 379.85M |
| Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.150B |
| Shareholders Equity (Quarterly) | 17.58B |
| Current Ratio | 3.987 |